Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Hansen Ree

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
BMC Cancer|July 12, 2023
Next-generation sequencing reveals mitogenome diversity in plasma extracellular vesicles from colorectal cancer patientsTonje Bjørnetrø, Paula A Bousquet, Kathrine Røe Redalen, et al.
Cancer Immunology Research|February 27, 2019
Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number GainAnne Hansen Ree, Vigdis Nygaard, Hege G Russnes, et al.
British Journal of Cancer|April 25, 2024
First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trialAnne Hansen Ree, Jūratė Šaltytė Benth, Hanne M Hamre, et al.
Oncotarget|November 5, 2017
Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastasesOlga Østrup, Vegar Johansen Dagenborg, Einar Andreas Rødland, et al.
Physics and Imaging in Radiation Oncology|January 31, 2023
Imaging the tumour microenvironment in rectal cancer: Decline in tumour blood flow during radiotherapy predicts good outcomeKine Mari Bakke, Sebastian Meltzer, Endre Grøvik, et al.
British Journal of Cancer|April 10, 2021
The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancerSebastian Meltzer, Annette Torgunrud, Hanna Abrahamsson, et al.
European Heart Journal|February 24, 2016
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprololGeeta Gulati, Siri Lagethon Heck, Anne Hansen Ree, et al.
Frontiers in Oncology|February 11, 2025
Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolismMarte Svalastoga, Trine-Lise Larsen, Jorunn Brekke, et al.
Acta Oncologica (Stockholm, Sweden)|December 17, 2021
MRI-based automatic segmentation of rectal cancer using 2D U-Net on two independent cohortsFranziska Knuth, Ingvild Askim Adde, Bao Ngoc Huynh, et al.
Journal of Thrombosis and Haemostasis : JTH|February 3, 2022
Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-upTrine-Lise Larsen, Herish Garresori, Jorunn Brekke, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
BMC Cancer|July 12, 2023
Next-generation sequencing reveals mitogenome diversity in plasma extracellular vesicles from colorectal cancer patientsTonje Bjørnetrø, Paula A Bousquet, Kathrine Røe Redalen, et al.
Cancer Immunology Research|February 27, 2019
Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number GainAnne Hansen Ree, Vigdis Nygaard, Hege G Russnes, et al.
British Journal of Cancer|April 25, 2024
First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trialAnne Hansen Ree, Jūratė Šaltytė Benth, Hanne M Hamre, et al.
Oncotarget|November 5, 2017
Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastasesOlga Østrup, Vegar Johansen Dagenborg, Einar Andreas Rødland, et al.
Physics and Imaging in Radiation Oncology|January 31, 2023
Imaging the tumour microenvironment in rectal cancer: Decline in tumour blood flow during radiotherapy predicts good outcomeKine Mari Bakke, Sebastian Meltzer, Endre Grøvik, et al.
British Journal of Cancer|April 10, 2021
The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancerSebastian Meltzer, Annette Torgunrud, Hanna Abrahamsson, et al.
European Heart Journal|February 24, 2016
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprololGeeta Gulati, Siri Lagethon Heck, Anne Hansen Ree, et al.
Frontiers in Oncology|February 11, 2025
Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolismMarte Svalastoga, Trine-Lise Larsen, Jorunn Brekke, et al.
Acta Oncologica (Stockholm, Sweden)|December 17, 2021
MRI-based automatic segmentation of rectal cancer using 2D U-Net on two independent cohortsFranziska Knuth, Ingvild Askim Adde, Bao Ngoc Huynh, et al.
Journal of Thrombosis and Haemostasis : JTH|February 3, 2022
Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-upTrine-Lise Larsen, Herish Garresori, Jorunn Brekke, et al.
Pageof 11